by John McCamant, editor The Medical technology Stock Letter
While the stock market is reeling, valuations are becoming unusually inexpensive and this is providing excellent opportunities for cool-headed investors.
Israel-based Teva Pharmaceuticals (TEVA) -- our latest buy recommendation -- offers diversification for our portfolios. It is a dynamic company with a fierce focus on growth.
Market News and Data brought to you by Benzinga APIsWhile the stock market is reeling, valuations are becoming unusually inexpensive and this is providing excellent opportunities for cool-headed investors.
Israel-based Teva Pharmaceuticals (TEVA) -- our latest buy recommendation -- offers diversification for our portfolios. It is a dynamic company with a fierce focus on growth.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: Health CarePharmaceuticals
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in